UPLOAD Filing
Medicus Pharma Ltd.
Date: Jan. 15, 2026 · CIK: 0001997296 · Accession: 0000000000-26-000556
AI Filing Summary & Sentiment
Reasoning
Letter
January 15, 2026 Raza Bokhari Executive Chairman and Chief Executive Officer Medicus Pharma Ltd. 300 Conshohocken State Road, Suite 200 Conshohocken, PA 19428 Re:Medicus Pharma Ltd. Draft Registration Statement on Form S-3 Submitted January 12, 2026 CIK No. 0001997296 Dear Raza Bokhari: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement and non-public draft submission on EDGAR at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Christopher Cummings
Show Raw Text
January 15, 2026
Raza Bokhari
Executive Chairman and Chief Executive Officer
Medicus Pharma Ltd.
300 Conshohocken State Road, Suite 200
Conshohocken, PA 19428
Re:Medicus Pharma Ltd.
Draft Registration Statement on Form S-3
Submitted January 12, 2026
CIK No. 0001997296
Dear Raza Bokhari:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement and non-public draft
submission on EDGAR at least two business days prior to the requested effective date and
time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Christopher Cummings